Brazil Medical Tourism: What Insurers Assess
The Brazil Corridor: What Insurers Assess When a New Medical Tourism Destination Opens
Most conversations about medical tourism destinations are about price. From an underwriting seat, price is close to the least interesting variable.
When a facilitator approaches us about a corridor we have not covered before, the assessment runs through a fairly consistent set of questions — and they are the same questions a patient should be asking, framed differently. Brazil is a useful case to work through, because it is simultaneously the largest cosmetic surgery market in the world and one of the least familiar to North American and Australian patients.
First, the scale question
Brazil performs more cosmetic surgical procedures than any other country on earth. The International Society of Aesthetic Plastic Surgery’s 2024 Global Survey puts the figure at roughly 2.3 million surgical procedures, ahead of the United States.
Volume matters to an underwriter for a simple reason: surgical outcomes correlate with surgical repetition. A market performing millions of procedures annually has a deep bench of high-volume surgeons, established supply chains, and hospitals that do this work every day rather than occasionally.
But there is a second number in that same survey that is more revealing. The countries with the highest proportion of foreign patients are Tunisia, the UAE, Colombia and Türkiye. Brazil does not appear on that list.
That tells you Brazil’s volume is overwhelmingly domestic — Brazilians operating on Brazilians. It is not an export industry in the way Türkiye’s is. From an insurance perspective that cuts both ways. A domestic market means less infrastructure built specifically for international patients: fewer English-speaking coordinators, fewer package operators, less logistical polish. It also means a surgeon’s reputation depends on local patients who can return to the clinic next month, which is a meaningful accountability mechanism that an export market does not always have.
Second, who is allowed to operate
This is the question that most often decides whether we can write a corridor at all.
Brazil separates the licence to practise medicine from the right to hold yourself out as a specialist. Every physician holds a CRM — a registration number issued by the medical council of the state they practise in, written as CRM-SP for São Paulo or CRM-RJ for Rio de Janeiro. Separately, a physician who has completed recognized specialist training in plastic surgery holds an RQE, a registered specialist qualification number.
Both are publicly verifiable through the Conselho Federal de Medicina. The national specialty society, the Sociedade Brasileira de Cirurgia Plástica, maintains its own searchable membership directory.
The gap to understand is that a physician with a CRM and no plastic surgery RQE can still legally perform cosmetic procedures in Brazil. That is not unique to Brazil — Australia only closed an equivalent gap through title reforms in 2023 — but it means the RQE, not the CRM, is the number that matters. A corridor where the facilitator verifies only that the doctor is a licensed physician is a materially different risk from one where the specialist qualification is checked.
Nuviya, the Australian-founded facilitator opening the Australia-to-Brazil cosmetic surgery corridor, verifies CRM and RQE registration for every surgeon on its platform and publishes both numbers on each surgeon’s profile. It also operates with a practising plastic surgeon as Chief Medical Officer rather than treating credentialing as an administrative function — which, from an underwriting perspective, is a meaningful structural difference.
“In Brazil the CRM tells you someone is a doctor. The RQE tells you they are a plastic surgeon. Those are not the same thing, and patients overseas have no reason to know the difference unless somebody explains it to them. Publishing both numbers is the simplest thing we can do — anyone can check them on the CFM portal without asking us for permission, which is the point.”
— Dr Leandro Gregório, plastic surgeon and Chief Medical Officer, Nuviya (CRM-SP 231278 / RQE 136020)
Third, where the surgery happens
An accredited hospital, a licensed day-surgery facility and a treatment room are three different risk environments, and the distinction is often invisible in a package brochure.
What we look for is the name of the facility, its accreditation status, whether a qualified anesthesiologist is present for the duration of the procedure, and what the escalation pathway to intensive care looks like. In markets where surgery has migrated heavily into standalone clinics, that last question becomes the important one.
Fourth, flight duration against the recovery window
This is where Brazil carries a genuine disadvantage relative to shorter-haul destinations, and it would be dishonest to gloss over it.
Long-haul air travel and major surgery both elevate venous thromboembolism risk. The relevant question is not how long the flight is, but how many nights the operating surgeon requires on the ground before clearing the patient to fly, and whether the package has actually budgeted for that many nights. A corridor where patients are flying home early to save on accommodation is a corridor with a predictable claims profile.
A 2026 study in the ANZ Journal of Surgery reviewing Australian patients presenting with complications after overseas cosmetic surgery found that more than half had undergone multiple concurrent procedures, half were active smokers, and one had developed a DVT or pulmonary embolism. The study covered a single hospital and a small cohort, so it should not be over-read — but the pattern it describes is the pattern underwriters price for.
Fifth, what happens after the patient is home
The corridor does not end at the departure gate. We want to know who reviews the patient once they are back, what the revision policy is and who pays for it, and whether there is a named clinical contact in the home country.
Corridors that have thought this through look materially different in claims experience from corridors that have not. It is also the part of the proposition most likely to be vague in marketing material, which makes it a useful question for patients to ask directly.
What this means for facilitators
New destinations open all the time, and the opening of a corridor is not by itself a signal of quality in either direction. Brazil brings genuine strengths — unmatched procedural volume, a demanding specialist training pathway, publicly verifiable credentials — alongside genuine constraints, principally distance and a market that was not built around international patients.
For a facilitator evaluating any new destination, the assessment is the same one we run: who can operate, where does it happen, does the timeline respect the clinical recovery window, and what is the plan for the small percentage of cases that do not go smoothly. Destinations that can answer those four questions in writing are the ones worth building a corridor into.
If you are opening a corridor into a new destination and want to understand how it would be underwritten, our team can walk you through the assessment. Call +1 (803) 799-1770 or email info@medicaltourisminsurance.com.
Sources
ISAPS Global Survey 2024, published June 2025 — Brazil first in surgical procedures at approximately 2.3 million; highest proportions of foreign patients recorded in Tunisia, the UAE, Colombia and Türkiye.
Conselho Federal de Medicina — CRM registration and RQE specialist qualification framework.
Sociedade Brasileira de Cirurgia Plástica — member directory.
